Exact Mass: 356.1736
Exact Mass Matches: 356.1736
Found 131 metabolites which its exact mass value is equals to given mass value 356.1736
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Pheniramine maleate
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics D018926 - Anti-Allergic Agents Same as: D01174
19-Epischolaricine
6-Amino-4-(4-phenoxyphenylethylamino)quinazoline
2,3,1,2,3,9-hexahydro-1H-[1,9]bi[pyrrolo[2,1-b]quinazolinyl]-9-one|Depegin|Dipegine
angustilodine|methyl 1,2,3,4,4a,5,11,11a-octahydro-11a-hydroxy-2-methyl-5,11-(oxydimethylene)-6H-pyrido[4,3-b]carbazole-5-carboxylate
4,4-Bis-methyl-5,5-<(1-methyltrimethylen)di>(methylnicotinate)|4,4-Bis-methyl-5,5-[(1-methyltrimethylen)di](methylnicotinate)|Alkaloid LA 5
Scholaricine
A natural product found in Alstonia scholaris and Alstonia species.
(-)-trans-verbenol beta-D-glucopyranoside 6-acetate
(cis)-chrysanthenol beta-D-glucopyranoside 6-acetate
8-Ac,Me ester-(1beta,4alpha,6alpha,8alpha)-1,4,6,8-Tetrahydroxy-11(13)-eudesmen-12-oic acid
2,6-dimethyl-3-hydroxymethyl-1,4,6-heptatriene-9-O-(6-acetyl-beta-D-glucopyranoside)
11-methoxyhumantenmine|4,20-dehydrogelsemicine|gelegamine D
Gly Pro Pro Ser
Gly Pro Ser Pro
Gly Ser Pro Pro
Pro Gly Pro Ser
Pro Gly Ser Pro
Pro Pro Gly Ser
Pro Pro Ser Gly
Pro Ser Gly Pro
Pro Ser Pro Gly
Ser Gly Pro Pro
Ser Pro Gly Pro
Ser Pro Pro Gly
Canangalia D
Proglumide sodium salt
Proglumide sodium is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide sodium selective blocks CCK’s effects in the central nervous system (CNS). Proglumide sodium has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide sodium also has antiepileptic and antioxidant activities[1][2][3][4][5].
{3-[2-(4-HYDROXY-PHENYL)-ACETYLAMINO]-BENZYL}-CARBAMICACIDTERT-BUTYLESTER
{4-[2-(4-HYDROXY-PHENYL)-ACETYLAMINO]-BENZYL}-CARBAMICACIDTERT-BUTYLESTER
N-(6-((tert-Butyldimethylsilyloxy)methyl)-2-chloropyridin-3-yl)pivalamide
5-O-TBDMS-thymidine
5'-O-TBDMS-dT is a nucleoside with protective and modification effects.
1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[2-(4-nitrophenyl)ethyl]-
Pheniramine maleate
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics D018926 - Anti-Allergic Agents
N-(3-aminopropyl)-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
2,2-spirobi[3,6,7,8-tetrahydro-1H-cyclopenta[g]naphthalene]-5,5-dione
1-[1-Ethyl-6-methyl-4-(4-phenyl-1-piperazinyl)-2-sulfanylidene-5-pyrimidinyl]ethanone
7-(4-Ethylpiperazin-1-yl)-14-methyl-10-thia-3,5,6,8-tetrazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2,4,7,11(16)-pentaene
N-[2-(4-fluorophenyl)ethyl]-2-[2-(2-hydroxyethylamino)-1-benzimidazolyl]acetamide
1-[(3-chlorophenyl)methyl]-N-methyl-N-(phenylmethyl)-3-piperidinecarboxamide
(4E)-4-[(2,5-dimethyl-1-pyridin-3-ylpyrrol-3-yl)methylidene]-5-methyl-2-phenylpyrazol-3-one
4-[4-[(1S,5R)-3-(4-oxazolylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile
3-[4-[(1S,5R)-3-(4-oxazolylmethyl)-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile
4-Ethoxycarbonyl-5-methyl-6-(1-propenyl)-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione
4-Ethoxycarbonyl-5-methyl-6-(1-propenyl)-2-(para-tolyl)perhydropyrrolo(3,4-C)pyrrole-1,3-dione (3A,4-trans-6,6A-cis)
ethyl (1R,3S,6aR)-2-methyl-5-(4-methylphenyl)-4,6-dioxo-1-[(E)-prop-1-enyl]-1,3,3a,6a-tetrahydropyrrolo[3,4-c]pyrrole-3-carboxylate
3’-O-t-Bulyldimethylsilylthymidine
3’-O-t-Bulyldimethylsilylthymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-[(6r)-6-ethenyl-2,6-dimethylcyclohex-1-en-1-yl]acetate
methyl 2-[(1s,2s,3s,4ar,5r,8r,8as)-3-(acetyloxy)-1,5,8-trihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate
22-methoxy-4,7,17,19-tetraazahexacyclo[15.8.0.0¹,⁵.0⁶,¹⁴.0⁸,¹³.0²⁰,²⁵]pentacosa-4,6(14),8,10,12,18,20,22,24-nonaene
(11s,12s,17s)-12-[(1s)-1-hydroxyethyl]-10-(methoxycarbonyl)-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,9-tetraen-14-ium-14-olate
4-(dodec-11-en-1-yl)-3-hydroxy-5-oxooxolane-2,3-dicarboxylic acid
(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-[(6s)-6-ethenyl-2,6-dimethylcyclohex-1-en-1-yl]acetate
11-Hydroxyrankinidine
{"Ingredient_id": "HBIN000452","Ingredient_name": "11-Hydroxyrankinidine","Alias": "Spiro(3H-indole-3,8'(7'H)-(4,7)methanooxepino(4,3-b)pyridin)-2(1H)-one, 3'-ethylidene-1',2',3',4',4'a,5',9',9'a-octahydro-6-hydroxy-1-methoxy-, (3S,3'Z,4'R,4'aS,7'R,9'aS)-; Humantenine, 4-demethyl-11-hydroxy-; 11-hydroxyrankinidine; (3'Z)-3'-ethylidene-6-hydroxy-1-methoxy-1',2',3',4',4a',5',9',9a'-octahydro-7'H-spiro[indole-3,8'-[4,7]methanooxepino[4,3-b]pyridin]-2(1H)-one; 122590-03-8; (7'Z)-7'-ETHYLIDENE-6-HYDROXY-1-METHOXY-11'-OXA-5'-AZASPIRO[INDOLE-3,2'-TRICYCLO[6.3.1.0?,?]DODECANE]-2-ONE; (7'Z)-7'-ETHYLIDENE-6-HYDROXY-1-METHOXY-11'-OXA-5'-AZASPIRO[INDOLE-3,2'-TRICYCLO[6.3.1.0?,?]DODECAN]-2-ONE; 9477AF; Nb-Demethyl-11-hydroxyhumantenine; BG01070136","Ingredient_formula": "C20H24N2O4","Ingredient_Smile": "CC=C1CNC2CC3(C4CC1C2CO4)C5=C(C=C(C=C5)O)N(C3=O)OC","Ingredient_weight": "356.4 g/mol","OB_score": "40.002764","CAS_id": "122590-03-8?","SymMap_id": "SMIT01195","TCMID_id": "10670","TCMSP_id": "MOL008411","TCM_ID_id": "NA","PubChem_id": "137705913","DrugBank_id": "NA"}
19-epi-scholaricine
{"Ingredient_id": "HBIN002183","Ingredient_name": "19-epi-scholaricine","Alias": "NA","Ingredient_formula": "C20H24N2O4","Ingredient_Smile": "CC(C1CN2CCC34C2CC1C(=C3NC5=C4C=CC=C5O)C(=O)OC)O","Ingredient_weight": "356.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35066","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101587171","DrugBank_id": "NA"}
6,7-seco-19,20-epoxyangustilobine b
{"Ingredient_id": "HBIN012100","Ingredient_name": "6,7-seco-19,20-epoxyangustilobine b","Alias": "NA","Ingredient_formula": "C20H24N2O4","Ingredient_Smile": "CN1CCC2C3(C1)C(O3)COCC2(C4=CC5=CC=CC=C5N4)C(=O)OC","Ingredient_weight": "356.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "19597","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101636548","DrugBank_id": "NA"}